Events & Congresses
Materials

XOSPATA patient brochure
Information about treatment with gilteritinib. It does not replace the package leaflet.
Read more
Gilteritinib post TKI (2022)
Publication
Clinical outcomes in patients with relapsed/refractory FLT3- mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
Read moreFLT3 testing methods
Video
Explanation of the practicalities of FLT3 testing and the difference between testing methods.
View more